J M Bell
Affiliation: South Australia
- Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolatesJ M Bell
National Antimicrobial Resistance Surveillance Program, Women s and Children s Hospital, North Adelaide, Australia
J Clin Microbiol 36:2187-90. 1998..Rapid and accurate methods are essential, because laboratory-based surveillance is critical in programs for the detection, control, and prevention of the transmission of glycopeptide-resistant enterococci...
- Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001J M Bell
Microbiology and Infectious Diseases Department, Women s and Children s Hospital, Adelaide, Australia
Antimicrob Agents Chemother 47:3989-93. 2003..A cefepime MIC above 0.25 microg/ml had the highest sensitivity (100%) and specificity (74%) for predicting the presence of an ESBL...
- Multicentre evaluation of the in vitro activity of linezolid in the Western PacificJan M Bell
Department of Microbiology and Infectious Diseases, Women s and Children s Hospital, 72 King William Road, North Adelaide, SA 5006, Australia
J Antimicrob Chemother 51:339-45. 2003..0.12-2 mg/L (1 mg/L) for S. pneumoniae and 0.25-2 mg/L (1 mg/L) for Streptococcus spp. There was no difference in linezolid susceptibility between countries or between multiresistant and susceptible strains of each species monitored...
- In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998-199Jan M Bell
Women s and Children s Hospital, Adelaide, Australia
Diagn Microbiol Infect Dis 43:315-8. 2002..pneumoniae (3 of which were resistant); in three strains of H. influenzae (MIC >/= 0.12 microg/mL), and 2 M. catarrhalis (MIC > 2 microg/mL)...
- Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99)Jan M Bell
Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide, South Australia
Diagn Microbiol Infect Dis 42:193-8. 2002..The best coverage against ESBL-producing isolates was obtained with imipenem (0% resistance), followed by amikacin (6% resistance)...
- SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South AfricaJan Bell
Microbiology and Infectious Diseases, Women s and Children s Hospital, Adelaide, South Australia
Commun Dis Intell Q Rep 27:S61-6. 2003..The data generated from SENTRY allows Australia to compare our antimicrobial resistance patterns and trends with our regional neighbours...
- Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756J M Bell
Int J Antimicrob Agents 19:125-32. 2002..8%. Both H. influenzae and M. catarrhalis isolates were uniformly susceptible to the new desfluoroquinolone and tested fluoroquinolones...
- Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific SurveilJan M Bell
Women s and Children s Hospital, Adelaide, South Australia 5006, Australia
J Clin Microbiol 45:1478-82. 2007..coli and K. pneumoniae from the Asia-Pacific region harbor important beta-lactamases, and a positive screening test alone should be sufficient grounds to report resistance to extended-spectrum cephalosporins in this region...
- Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia. Pneumococcal Study GroupJ D Turnidge
Women s and Children s Hospital, Adelaide, SA
Med J Aust 170:152-5. 1999..To examine the prevalence of resistance in Streptococcus pneumoniae to key antimicrobials in Australia during 1997...
- Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agentsJ M Bell
Department of Microbiology and Infectious Diseases, Women's and Children's Hospital, Adelaide, South Australia
Pathology 33:53-60. 2001..Enterococci, Bacillus species, Burkholderia cepacia and Stenotrophomonas maltophilia were predicably resistant. Cefepime has a spectrum of activity almost as broad as that of the carbapenems...
- Identification of plasmid-mediated extended-spectrum and AmpC beta-lactamases in Enterobacter spp. isolated from dogsHanna E Sidjabat
School of Veterinary Science, The University of Queensland, Brisbane, QLD 4072, and Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide, SA, Australia
J Med Microbiol 56:426-34. 2007..Therefore, Enterobacter isolated from opportunistic infections in dogs may be an important reservoir of plasmid-mediated resistance genes, which could potentially be spread to other members of the Enterobacteriaceae...
- Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008)Jan M Bell
Microbiology and Infectious Diseases Directorate, SA Pathology, Women s and Children s Hospital, Adelaide, South Australia
Pathology 42:470-3. 2010..To assess in vitro activity and spectrum of daptomycin, a new lipopeptide antimicrobial, against contemporary isolates of Gram positive pathogens in Australia and New Zealand in 2008...
- Methicillin-resistant Staphylococcal aureus evolution in Australia over 35 yearsJ D Turnidge
Department of Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide, South Australia, Australia
Microb Drug Resist 6:223-9. 2000..It has a similar antibiogram to the western strains, but an entirely different epidemiology, resembling that currently being experienced in parts of New Zealand, and associated with patients of south Pacific island origin...
- Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using clinical and laboratory standards institute methods: a SENTRY antimicrobial surveillance program reportJan M Bell
SA Pathology at the Women s and Children s Hospital, North Adelaide, South Australia, Australia
J Clin Microbiol 47:2187-93. 2009..The proposed interpretive criteria were highly accurate, with <or=0.7% very major (falsely susceptible) and <or=1.0% major (falsely resistant) errors, respectively...
- High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999Jan M Bell
Department of Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide SA 5006, Australia
Antimicrob Agents Chemother 46:879-81. 2002..No vancomycin-intermediate strains were detected, and no strains were resistant to linezolid or quinupristin-dalfopristin. MORSA strains are a very common cause of infection in hospitalized patients in the APAC region...
- aac(6')-Ib-cr genotyping by simultaneous high-resolution melting analyses of an unlabeled probe and full-length ampliconJan M Bell
SA Pathology, Women s and Children s Hospital, 72 King William Rd, North Adelaide, SA 5006, Australia
Antimicrob Agents Chemother 54:1378-80. 2010..Our genotyping assay uses the combined information of simultaneously acquired high-resolution melting data from an unlabeled probe and the full-length amplicon...
- Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999Graeme R Nimmo
Microbiology Department, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba 4102, Australia
Microb Drug Resist 9:155-60. 2003..The proportion of nmMRSA increased to modest levels in the other cities. In eastern cities, this was due to the appearance of strains closely related to nmMRSA seen in other countries of the southwestern Pacific...
- Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)Douglas J Biedenbach
JMI Laboratories, 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317, USA
Int J Antimicrob Agents 30:143-9. 2007..Daptomycin was demonstrated to have excellent in vitro activity when tested against Gram-positive isolates collected from Asia-Pacific countries, including hVISA strains...
- Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial ResistanceGraeme R Nimmo
Division of Microbiology, Queensland Health Pathology Service, Central Laboratory, Herston
Commun Dis Intell Q Rep 31:288-96. 2007..Further investigation is warranted as reductions in prevalence would reduce morbidity, mortality and healthcare costs...
- Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 geneRodrigo E Mendes
Antimicrob Agents Chemother 52:798-9. 2008
- Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: report from the Australian Group on Antimicrobial ResistanceKeryn J Christiansen
Department of Microbiology and Infectious Diseases, PathWest Laboratory Medicine, Royal Perth Hospital, Western Australia
Commun Dis Intell 31:392-7. 2007....
- Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005: report from the Australian Group on Antimicrobial ResistanceThomas Gottlieb
Department of Microbiology and Infectious Diseases, Concord Hospital, Concord, New South Wales
Commun Dis Intell Q Rep 32:242-9. 2008..6% to 5.4%. After a rapid emergence and rise in resistance between 1989 and 1999, recent studies have documented a continuing rise in resistance to all non-beta-lactams except trimethoprim-sulphamethoxazole...
- Identification of bla(CMY-7) and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in AustraliaHanna E Sidjabat
School of Veterinary Science, The University of Queensland, Brisbane, QLD 4072, Australia
J Antimicrob Chemother 57:840-8. 2006..To determine clonality and identify plasmid-mediated resistance genes in 11 multidrug-resistant Escherichia coli (MDREC) isolates associated with opportunistic infections in hospitalized dogs in Australia...
- Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymesAnton Y Peleg
J Antimicrob Chemother 57:794-5. 2006
- Fifteen years of surveillance by the Australian Group for Antimicrobial Resistance (AGAR)Graeme R Nimmo
Queensland Health Pathology Services, Princess Alexandra Hospital, Brisbane, Queensland
Commun Dis Intell Q Rep 27:S47-54. 2003..The recent extension of membership to include more private pathology laboratories may provide the opportunity to conduct more representative community based surveys...
- Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002)Ronald N Jones
The JONES Group JMI Laboratories, North Liberty, IA, USA
Diagn Microbiol Infect Dis 49:289-94. 2004....
- Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in AustraliaGeoffrey W Coombs
Gram positive Bacteria Typing and Research Unit, Royal Perth Hospital, Australia
J Clin Microbiol 42:4735-43. 2004..These findings provide support for the acquisition of SCCmec by multiple lineages of S. aureus. They also confirm that both hospital and community strains of MRSA are now common in nonhospitalized patients throughout Australia...
- Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverageMichael Watson
New South Wales Pneumococcal Reference Laboratory, Department of Microbiology, Children s Hospital at Westmead, New South Wales
Commun Dis Intell Q Rep 27:478-87. 2003....
- Dissemination of new methicillin-resistant Staphylococcus aureus clones in the communityKeiko Okuma
Department of Bacteriology, Juntendo University, Tokyo, Japan
J Clin Microbiol 40:4289-94. 2002..They multiplied much faster than health-care-associated MRSA and were resistant to fewer non-beta-lactam antibiotics. They seem to have been derived from more diverse S. aureus populations than health-care-associated MRSA strains...
- Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine programMichael Watson
The NSW Pneumococcal Reference Laboratory, Department of Microbiology, The Children s Hospital at Westmead, Westmead, New South Wales
Commun Dis Intell Q Rep 28:455-64. 2004....
- Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002)Yoichi Hirakata
Department of Laboratory Medicine, School of Medicine, Nagasaki University, Nagasaki 852 8501, Japan
Diagn Microbiol Infect Dis 52:323-9. 2005..Imipenem retained activity against all ESBL-producing strains. Organisms expressing ESBLs are widely distributed in the Asia-Pacific region, although prevalence rates vary significantly...
- Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in AustraliaAnton Y Peleg
Infectious Diseases and Microbiology Department, The Alfred Hospital, Melbourne, Australia
Clin Infect Dis 41:1549-56. 2005..We describe the first outbreak in Australia of infection and/or colonization with gram-negative pathogens carrying the MBL gene blaIMP-4...
- OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from AustraliaAnton Y Peleg
Antimicrob Agents Chemother 50:399-400. 2006
- Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in AustraliaAnton Y Peleg
Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia
Infect Control Hosp Epidemiol 27:759-61. 2006..Selected isolates were of the same clonal type, and no genes encoding carbapenemases were identified...
- Activity of a peptide deformylase inhibitor LBM415 (NVP PDF-713) tested against recent clinical isolates from JapanJan M Bell
J Antimicrob Chemother 55:276-8. 2005